Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Pemetrexed + Cisplatin for Metastatic/Recurrent Soft Tissue Sarcoma (4 Histologic Subtypes)
KCT0005369Phase 2Recruiting
- Sponsor
- Boryung
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed, cisplatin in soft tissue sarcoma (STS), sponsored by Boryung. Started Dec 2020; status: recruiting.
02
Drugs
pemetrexedcisplatin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on KCT0005369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005369.